PRKAA2 and cancer: AMPK inhibits essentially all anabolic pathways that promote cell growth including fatty acids, phospholipids, protein and ribosomal RNA synthesis [1, 24]; thus, in cancer where the energy demands of the cell are elevated due to rapid growth and division AMPK activators may be a suitable therapeutic intervention for treating cancer.